Milton Rossman is a Respiratory physician affiliated with University of Pennsylvania. OpenAlex indexes 155 publications with 9,339 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
Philadelphia, PA 19104
Telephone
215-662-3202Registry record last updated 31 Mar 2011.
Clinical trials
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
- A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20234 payments
- Boehringer Ingelheim International GmbHProgram year20221 payment
- Boehringer Ingelheim International GmbHProgram year20214 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
39.8%Corticosteroid30.5%Prednisone100%Part D≥18 patientsProton pump inhibitor9.4%Omeprazole100%Part D<11 patientsRespiratory
31.2%beta2-Adrenergic Agonist21.1%Albuterol Sulfate Hfa100%Part D≥14 patientsCorticosteroid10.2%Trelegy Ellipta100%Part D<11 patientsCancer & immunology
28.9%Folate Analog Metabolic Inhibitor18%Methotrexate100%Part D<11 patientsKinase inhibitor10.9%Ofev100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1985–2014 per NIH RePORTER. The latest:
- GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research
University of Pennsylvania
FY2014$156,800U01HL112712 - GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research
University of Pennsylvania
FY2013$152,320U01HL112712 - GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research
University of Pennsylvania
FY2012$160,000U01HL112712
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low–Microbial Content Samples
American Journal of Respiratory and Critical Care Medicine
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”